Dr. Nabavizadeh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
20 Duke Medicine Cir Durham, NC
Durham, NC 27710Phone+1 919-668-6688
Summary
- Dr. Reza Nabavizadeh is a urologic oncologist based at Duke University in Durham, NC. He completed his residency in urology at Emory University School of Medicine from 2017 to 2022, following his graduation from Virginia Commonwealth University School of Medicine in 2017. His research work, which has been published in various journals covers various topics including renal cell carcinoma, testicular cancer, bladder cancer, preoperative frailty assessments, and oncologic outcomes of prostate cancer surgery. His work is noted for its contributions to understanding tumor thrombus in renal cell carcinoma and the impact of lymph-node metastasis and seminal vesicle invasion in prostate cancer.
Education & Training
- Emory University School of MedicineResidency, Urology, 2017 - 2022
- Virginia Commonwealth University School of MedicineClass of 2017
Certifications & Licensure
- NC State Medical License 2024 - 2025
- WI State Medical License 2022 - 2025
- MN State Medical License 2022 - 2024
Publications & Presentations
PubMed
- Renal Cell Carcinoma With Venous Tumor Thrombus Has a Predilection for the Lungs.Reza Nabavizadeh, Rodrigo Rodrigues Pessoa, John C Cheville, Christine M Lohse, Brian A Costello
Urology. 2024-12-27 - 2 citationsRelative impact of lymph-node metastasis and seminal vesical invasion on oncologic outcomes following radical prostatectomy.Rodrigo Rodrigues Pessoa, Reza Nabavizadeh, Paras Shah, Igor Frank, Mathew Tollefson
Prostate Cancer and Prostatic Diseases. 2024-12-01 - Role of B7-H3 in predicting response to neoadjuvant chemotherapy in muscle-invasive bladder cancer.Ekamjit S Deol, Reza Nabavizadeh, Roxane R Lavoie, Mihai G Dumbrava, Edlira Horjeti
BJUI Compass. 2024-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: